267
Views
3
CrossRef citations to date
0
Altmetric
CLINICAL TRIAL REPORT

Relative Safety and Efficacy of Two Doses of Tandospirone Citrate for Generalized Anxiety Disorder: A Multicenter Randomized Controlled Trial

, , , , , , , & show all
Pages 1653-1664 | Received 11 Mar 2022, Accepted 01 Aug 2022, Published online: 08 Aug 2022

References

  • Stein MB, Sareen J, Solomon CG. CLINICAL PRACTICE. Generalized anxiety disorder. N Engl J Med. 2015;373(21):2059–2068. doi:10.1056/NEJMcp1502514
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Washington: DC: American Psychiatric Association; 2013.
  • Guo X, Meng Z, Huang G, et al. Meta-analysis of the prevalence of anxiety disorders in mainland China from 2000 to 2015. Sci Rep. 2016;6:28033. doi:10.1038/srep28033
  • Huang Y, Zhao N. Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey. Psychiatry Res. 2020;288:112954. doi:10.1016/j.psychres.2020.112954
  • Huang Y, Wang Y, Wang H, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study. Lancet Psychiatry. 2019;6(3):211–224. doi:10.1016/S2215-0366(18)30511-X
  • Reinhold JA, Rickels K. Pharmacological treatment for generalized anxiety disorder in adults: an update. Expert Opin Pharmacother. 2015;16(11):1669–1681. doi:10.1517/14656566.2015.1059424
  • Kapczinski FLM, Souza JS, Schmitt R. Antidepressants for generalized anxiety disorder. Cochrane Database Syst Rev. 2003;68:CD003592–CD003592.
  • Corey-Lisle PK, Nash R, Stang P, Swindle R. Response, partial response, and nonresponse in primary care treatment of depression. Arch Intern Med. 2004;164(11):1197–1204. doi:10.1001/archinte.164.11.1197
  • Dunlop BW, Davis PG. Combination treatment with benzodiazepines and SSRIs for comorbid anxiety and depression: a review. Prim Care Companion J Clin Psychiatry. 2008;10(3):222–228. doi:10.4088/PCC.v10n0307
  • Clayton AH, Pradko JF, Croft HA, et al. Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry. 2002;63(4):357–366. doi:10.4088/JCP.v63n0414
  • Werneke U, Northey S, Bhugra D. Antidepressants and sexual dysfunction. Acta Psychiatr Scand. 2006;114(6):384–397. doi:10.1111/j.1600-0447.2006.00890.x
  • Moll JL, Brown CS. The use of monoamine pharmacological agents in the treatment of sexual dysfunction: evidence in the literature. J Sex Med. 2011;8(4):956–970. doi:10.1111/j.1743-6109.2010.02190.x
  • Phillips MR, Zhang J, Shi Q, et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001–05: an epidemiological survey. Lancet. 2009;373(9680):2041–2053. doi:10.1016/S0140-6736(09)60660-7
  • Chollet J, Saragoussi D, Clay E, Francois C. A clinical research practice datalink analysis of antidepressant treatment patterns and health care costs in generalized anxiety disorder. Value Health. 2013;16(8):1133–1139. doi:10.1016/j.jval.2013.09.001
  • Huang X, Yang J, Yang S, et al. Role of tandospirone, a 5-HT1A receptor partial agonist, in the treatment of central nervous system disorders and the underlying mechanisms. Oncotarget. 2017;8(60):102705–102720. doi:10.18632/oncotarget.22170
  • Hamik A, Oksenberg D, Fischette C, Peroutka SJ. Analysis of tandospirone (SM-3997) interactions with neurotransmitter receptor binding sites. Biol Psychiatry. 1990;28(2):99–109. doi:10.1016/0006-3223(90)90627-E
  • Liao Z, Zhao X, Li T, et al. EEG power spectral analysis reveals tandospirone improves anxiety symptoms in patients with Alzheimer’s disease: a prospective cohort study. Ann Transl Med. 2021;9(1):64. doi:10.21037/atm-20-6647
  • Lin J, Su Y, Wang C, et al. Effects of tandospirone augmentation in major depressive disorder patients with high anxiety: a multicenter, randomized, parallel-controlled, open-label study. J Psychiatr Res. 2018;99:104–110. doi:10.1016/j.jpsychires.2018.01.020
  • Wu W, Li C, Fang F, et al. Effectiveness of tandospirone in treatment of patients with general anxiety disorder and its impact on quality of life: a multicenter open study. Chin J New Drug Clin Rem. 2006;4:282–285.
  • Shimizu H, Tatsuno T, Tanaka H, Hirose A, Araki Y, Nakamura M. Serotonergic mechanisms in anxiolytic effect of tandospirone in the Vogel conflict test. Jpn J Pharmacol. 1992;59(1):105–112. doi:10.1254/jjp.59.105
  • Nishitsuji K, To H, Murakami Y, et al. Tandospirone in the treatment of generalised anxiety disorder and mixed anxiety-depression: results of a comparatively high dosage trial. Clin Drug Investig. 2004;24(2):121–126. doi:10.2165/00044011-200424020-00007
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington: DC: American Psychiatric Association; 2000.
  • Mingyuan Z. Handbook of Psychiatric Scales. Hunan: Hunan Science and Technology Press; 1998.
  • Maier W, Buller R, Philipp M, Heuser I. The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. J Affect Disord. 1988;14(1):61–68. doi:10.1016/0165-0327(88)90072-9
  • Bereza BG, Machado M, Ravindran AV, Einarson TR. Evidence-based review of clinical outcomes of guideline-recommended pharmacotherapies for generalized anxiety disorder. Can J Psychiatry. 2012;57(8):470–478. doi:10.1177/070674371205700805
  • Rickels K, Zaninelli R, McCafferty J, Bellew K, Iyengar M, Sheehan D. Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2003;160(4):749–756. doi:10.1176/appi.ajp.160.4.749
  • Davidson JR, Bose A, Korotzer A, Zheng H. Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study. Depress Anxiety. 2004;19(4):234–240. doi:10.1002/da.10146
  • Allgulander C, Dahl AA, Austin C, et al. Efficacy of sertraline in a 12-week trial for generalized anxiety disorder. Am J Psychiatry. 2004;161(9):1642–1649. doi:10.1176/appi.ajp.161.9.1642
  • Brawman-Mintzer O, Knapp RG, Rynn M, Carter RE, Rickels K. Sertraline treatment for generalized anxiety disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2006;67(6):874–881. doi:10.4088/JCP.v67n0603
  • Meoni P, Hackett D, Lader M. Pooled analysis of venlafaxine XR efficacy on somatic and psychic symptoms of anxiety in patients with generalized anxiety disorder. Depress Anxiety. 2004;19(2):127–132. doi:10.1002/da.10141
  • Balon R, Starcevic V. Role of benzodiazepines in anxiety disorders. Adv Exp Med Biol. 2020;1191:367–388.
  • Craske MG, Stein MB. Anxiety. Lancet. 2016;388(10063):3048–3059. doi:10.1016/S0140-6736(16)30381-6
  • Hettema JM. The nosologic relationship between generalized anxiety disorder and major depression. Depress Anxiety. 2008;25(4):300–316. doi:10.1002/da.20491
  • Chen H, Lin Q, Lin T, et al. A controlled study of the efficacy and safety of tandospirone citrate combined with escitalopram in the treatment of vascular depression: a pilot randomized controlled trial at a single-center in China. J Psychiatr Res. 2019;114:133–140. doi:10.1016/j.jpsychires.2019.04.024
  • Wu WY, Wang G, Ball SG, Desaiah D, Ang QQ. Duloxetine versus placebo in the treatment of patients with generalized anxiety disorder in China. Chin Med J. 2011;124(20):3260–3268.